JAKSCH FRANK L JR (EXECUTIVE CHAIRMAN OF BOARD) sold 13.2% of their position (37.16K shares) of NIAGEN BIOSCIENCE, INC. on the open market
Open‑market sale worth $230.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/13/2024ACC: 0001628280-24-051264
DirectorOfficer· EXECUTIVE CHAIRMAN OF BOARD
Since Feb 2019
-37.16K
Net shares
Net seller
$230.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
50K acquired · 87.16K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
$3.66
Trade value
$183K
% of position
21.6%
12/13/2024
231.34K→281.34K
Common Stock
Direct
Shares
−37.16K
Price / share
$6.19
Trade value
$229.96K
% of position
13.2%
12/13/2024
281.34K→244.18K
Total
Net shares
+12.84K
Net value
-$46.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/13/2024 | M · Option Exercise | +50K | $3.66 | $183K | 21.6% | 231.34K | 281.34K |
| Common Stock Direct | 12/13/2024 | S · Sale | −37.16K | $6.19 | $229.96K | 13.2% | 281.34K | 244.18K |
| Total | +12.84K | -$46.95K | ||||||
Derivative Transactions1
Employee Stock Options (right to buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
3.66
Held after
0.00
Exercisable
—
12/13/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Options (right to buy) Direct | Common Stock50K shares | 12/13/2024 | M · Option Exercise | −50K | 3.66 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.08M
Total
2.08M indirect2.08M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.08M | Indirect |
| Total | 2.08M | 2.08M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported